Abstract:Background Polygenic risk scores (PRS) have ushered in a new era in genetic epidemiology, offering insights into individual predispositions to a wide range of diseases. However, despite recent marked enhancements in their predictive power, there are still challenges that need to be overcome before PRS-based models can be broadly applied in the clinic, including sufficient accuracy, easy interpretability and portability across diverse populations. Methods Leveraging trans-ancestry genome-wide association study (GWAS) meta-analysis, we generated novel, diverse summary statistics for 30 medically-related traits which were used to benchmark the performance of six existing PRS algorithms using UK biobank. Observing that SBayesRC had the best overall performance but recognizing strengths in each method, we developed an ensemble PRS model using logistic regression to combine outputs from top-performing algorithms. This ensemble model was validated on the diverse eMERGE and PAGE MEC cohorts, and the performance was compared against current state-of-the-art PRS models. To enhance predictive accuracy for clinical application, we incorporated easily-accessible clinical characteristics such as age, gender, ancestry and risk factors, creating disease prediction models intended as prospective diagnostic tests, with easily interpretable positive or negative outcomes. Results Predictive performance of PRS models improved with trans-ancestry GWAS meta-analysis and was further enhanced by the ensemble model, which surpassed state-of-art PRS models. When applied to external cohorts, performance drops were minimal, indicating good calibration. After adding clinical characteristics, 12 out of 30 models surpassed 80% AUC. Further, 25 traits exceeded the diagnostic odds ratio (DOR) of 5 and 19 traits exceeded DOR of 10 for all ancestry groups, indicating high predictive value. The highest DOR in a population with a sufficient number of cases was 66.2 for Alzheimer's disease in Europeans. Our PRS model for coronary artery disease identified 55-80 times more true coronary events than rare pathogenic variant models, reinforcing its clinical potential. The polygenic component modulated the effect of high-risk rare variants, stressing the need to consider all genetic components in clinical settings. Conclusions Newly developed PRS-based disease prediction models have sufficient accuracy and portability to warrant consideration of being used in the clinic.

Systems biology approaches to utilise polygenic risk scores for chronic diseases

Polygenic risk scores: from research tools to clinical instruments

Methodologies underpinning polygenic risk scores estimation: a comprehensive overview

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations

Optimization of Multi-Ancestry Polygenic Risk Score Disease Prediction Models

Polygenic Risk Scores and Genetically Complex Eye Disease

A perspective on genetic and polygenic risk scores—advances and limitations and overview of associated tools

Polygenic risk scores for the prediction of cardiometabolic disease

A Deep Learning-based Genome-wide Polygenic Risk Score for Common Diseases Identifies Individuals with Risk

Implementing polygenic risk scores in the clinic

Polygenic scores and their applications in kidney disease

Predicting the status of human complex diseases with random forest and polygenic risk scores

How to improve polygenic prediction from whole-genome sequencing data by leveraging predicted epigenomic features?

Polygenic Risk Scores: The Next Step for Improved Risk Stratification in Coronary Artery Disease?

Identifying and characterizing disease subpopulations that most benefit from polygenic risk scores

Risk assessment for colorectal cancer via polygenic risk score and lifestyle exposure: a large-scale association study of East Asian and European populations

A comprehensive investigation of statistical and machine learning approaches for predicting complex human diseases on genomic variants

Applying polygenic risk score methods to pharmacogenomics GWAS: challenges and opportunities

Feature Selection for Polygenic Risk Scores using Genetic Algorithm and Network Science

Current State and Future of Polygenic Risk Scores in Cardiometabolic Disease: A Scoping Review

Principles and methods for transferring polygenic risk scores across global populations